Stay updated on REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.2 to v3.6.3. This signals a minor page/template update rather than any changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-05T04:30:34.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.0 to v3.6.2, representing an internal update to the ClinicalTrials.gov page. Substantive study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-06-27T23:45:24.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Recruitment status updated to No longer looking for participants, indicating the study is not enrolling. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading was adjusted for consistency.
    Difference
    0.3%
    Check dated 2026-06-13T17:16:39.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous v3.5.4. This reflects a small update to the page's revision history rather than any substantive change to study details or navigation.
    Difference
    0.0%
    Check dated 2026-06-06T13:23:40.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page’s revision metadata was updated from v3.5.3 to v3.5.4, indicating an internal platform update. There is no indication that the study content or user-facing information was altered.
    Difference
    0.0%
    Check dated 2026-05-16T07:36:43.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number has been updated from **v3.5.2** to **v3.5.3**. This reflects a site or interface release rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-24T05:57:58.000Z thumbnail image

Stay in the know with updates to REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.